5 FDA/FTC Compliance Mistakes in Health Content (And How to Avoid Them)

If you publish health content, especially for supplement, wellness, or functional medicine brands, you are operating under regulatory scrutiny that most content creators do not fully understand. The FDA regulates product labeling and health claims. The FTC regulates advertising, which includes your blog posts, social media, and email marketing if they promote a product.

The penalties are not theoretical. The FTC regularly sends warning letters to health brands for deceptive content, and enforcement actions can result in significant financial penalties. And even if enforcement never reaches you directly, Google's algorithms increasingly penalize content that makes unsupported health claims, so bad compliance is bad SEO too.

Here are the five mistakes we see most often, along with the specific fixes.

Mistake 1: Using Disease Claims for Supplements

This is the most dangerous mistake and the most common. A disease claim states or implies that a product can prevent, treat, cure, or diagnose a specific disease. Under the Dietary Supplement Health and Education Act (DSHEA), supplements cannot make disease claims. Period.

Examples of disease claims in content:

• "Our turmeric supplement reduces inflammation associated with arthritis"
• "Vitamin D supplementation prevents osteoporosis"
• "Take berberine to manage your Type 2 diabetes"

Each of these links a supplement to a specific disease or diagnosed condition. That is a disease claim, and it violates FDA regulations regardless of whether the underlying science supports it.

How to fix it:

Use structure/function claims instead. These describe how a nutrient affects the normal structure or function of the body without referencing a specific disease.

• ❌ "Reduces arthritis inflammation" → ✅ "Supports joint comfort and healthy inflammatory response"
• ❌ "Prevents osteoporosis" → ✅ "Supports bone density and calcium absorption"
• ❌ "Manages Type 2 diabetes" → ✅ "Supports healthy blood sugar levels already within the normal range"

The qualifier "already within the normal range" is important. It signals that you are talking about maintaining normal function, not treating a disease state.

Also: every supplement making a structure/function claim must include the FDA disclaimer: "These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease."

Mistake 2: Disguising Claims as Education

Many brands try to create a separation between their "educational" blog content and their product pages, thinking that educational content is exempt from FTC advertising rules. It is not.

If your blog post discusses the benefits of an ingredient and that blog post lives on the same site that sells a supplement containing that ingredient, the FTC can consider it advertising. The connection between content and commerce does not need to be explicit. If a reasonable consumer would understand the content as promoting a product, it falls under FTC jurisdiction.

The pattern that gets brands in trouble:

A blog post titled "10 Benefits of Ashwagandha for Stress" that reads as neutral educational content but includes a link or CTA to the brand's ashwagandha product. The FTC views the entire article as promotional material, and every claim in it must be substantiated.

How to fix it:

Treat every piece of content on your brand's domain as potentially promotional. This does not mean you cannot publish educational content. It means every health claim in that content needs adequate substantiation, typically in the form of competent and reliable scientific evidence.

Before publishing, ask: "If the FTC reviewed every claim in this article, could we back each one with published, peer-reviewed research?" If the answer is no for any claim, revise it.

Mistake 3: Cherry-Picking Study Results

The FTC's standard for substantiation requires that claims be supported by the "totality of the evidence," not just the studies that support your position. Citing one favorable study while ignoring three that found no effect is exactly the kind of selective representation that triggers FTC action.

Example:

You find one small study showing that your branded probiotic strain improves immune function. You base an entire blog post on this study. But there are also two larger studies showing no statistically significant immune benefit for that strain. By citing only the favorable study, you are presenting a misleading picture of the evidence.

How to fix it:

When citing research to support health claims, consider the full body of evidence:

• Prioritize systematic reviews and meta-analyses over individual studies.
• If the evidence is mixed, say so. "Some research suggests" is both more accurate and more defensible than "research proves."
• Distinguish between preliminary findings (cell studies, animal studies, small pilot trials) and strong clinical evidence (large RCTs, replicated findings).
• Never present a single study as definitive proof of a health benefit.

Honest representation of evidence is not just good compliance. It is good E-E-A-T, and Google rewards it.

Mistake 4: Unsubstantiated Testimonials and Reviews

Customer testimonials and reviews are marketing gold for health brands, but they carry significant FTC risk. The FTC requires that testimonials reflect typical results. If a customer says "I lost 30 pounds in two months with this supplement," you can only use that testimonial if 30 pounds in two months is a typical result for users.

The old disclaimer "Results not typical" no longer provides legal protection. The FTC revised its guidance to require that testimonials either reflect typical outcomes or clearly disclose what typical outcomes actually are.

The content mistake:

Publishing customer success stories, case studies, or reviews that highlight exceptional results without disclosing typical outcomes. This applies to blog content, social media posts, email marketing, and any other format where testimonials appear.

How to fix it:

• If you use testimonials, include clear disclosure of typical results: "Most users experience [X typical outcome] when combined with [diet/exercise/routine]."
• Do not edit testimonials to make claims stronger. If a customer wrote "I feel like I have more energy," do not rephrase it as "Gives you boundless energy."
• For blog content featuring success stories, include a clear disclaimer about individual variation and typical results.
• If you do not have data on typical results, do not use result-specific testimonials. Instead, use testimonials that describe experience ("I enjoyed the taste" or "Easy to incorporate into my routine") rather than outcomes.

Mistake 5: Ignoring Implied Claims

This is the most subtle mistake. An implied claim is one that a reasonable consumer would take away from your content, even if you never stated it explicitly.

Examples of implied claims:

• An image of a supplement next to a blood pressure monitor, implying the supplement affects blood pressure
• A blog post titled "Natural Alternatives to Statins" that discusses your cholesterol-support supplement
• Using the phrase "clinically proven" without specifying what was proven, in what study, and at what dosage
• Before/after imagery that implies a supplement caused visible physical changes

The FTC evaluates claims based on "net impression," meaning the overall message a reasonable consumer takes away from your content. Even if every individual sentence is technically compliant, the combined effect of your content can create an implied claim that violates regulations.

How to fix it:

Review your content from the perspective of a reasonable consumer who knows nothing about supplement regulations. What would they believe after reading your article? If the answer includes any disease claims, treatment promises, or exaggerated benefits that you cannot substantiate, revise the content.

Specific steps:

• Audit your imagery and graphics for implied associations with diseases or medical treatments
• Review headlines and subheadings for implied claims (headlines are often more aggressive than the body text supports)
• Check CTAs for language that implies guaranteed outcomes ("Get relief now," "Start healing today")
• Have someone outside your organization read the content and tell you what they believe the product does. Their interpretation is what the FTC will evaluate.

Building a Compliance Review Process

The most effective way to avoid these mistakes is to build compliance review into your content workflow, not as an afterthought but as a standard step before publication.

Here is a simple compliance checklist:

1. Are there any explicit disease claims? Flag and revise.
2. Are there any implied disease claims in headlines, images, or CTAs? Flag and revise.
3. Is every specific health claim supported by the totality of available evidence?
4. Do any testimonials or case studies represent atypical results without disclosure?
5. Does educational content link to or implicitly promote specific products?
6. Are all required disclaimers present and visible?

Have someone with regulatory knowledge review content against this checklist before every publication. A 30-minute compliance review costs far less than a warning letter or enforcement action.

Regulatory compliance is not a creativity killer. It forces better, more honest content. And in a search environment where Google increasingly rewards accuracy and trustworthiness, compliant content performs better by every measure.

---